newsfilter
← Latest News
ClinicalTrials.gov·

Study of ALXN2050 in Adult Participants With Generalized Myasthenia Gravis - NCT05218096

Proportion Of Participants With A Myasthenia Gravis Activities of Daily Living (MG-ADL) Total Score Reduction Of ≥ 2 Points In Any 4 Consecutive Weeks During The First 8 Weeks And Who Did Not Receive Rescue Therapy, Change From Baseline In Quantitative Myasthenia Gravis (QMG) Total Score At Week 8, Proportion Of Participants Meeting Prespecified Threshold In The QMG Total Score At Week 8, (and 12 more...)